Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy

業績番号：2021-3

H.Mashima, R.Zhang, T.Kobayashi, H.Tsukamoto, T.Liu, T.Iwama, Y.Hagiya, M.Yamamoto, S.Fukushima, S.Okada, A.Idiris, S.Kaneko, T.Nakatsura, H.Ohdan and Y.Uemura

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy

Molecular Therapy Methods&Clinical Development 21; 171:179; 2021.7.11

33816647

https://doi.org/10.1016/j.omtm.2021.03.002